Skip to main content
Caplight Logo









Circulate Health

Circulate Health

Private
Seattle, WashingtonHealthcare & Life Scienceshttps://circulate.health/

Last Round

Strategic

Dec 3, 2025

Total Funding Raised

$12M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Circulate Health is a biotechnology company that provides therapeutic plasma exchange (TPE) treatments to reverse aging and improve health outcomes.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Precision Medicine

Business Model

B2B2C

Customer Profile

Services & Consulting, Hardware + Subscription

AI Layer

Non-AI

Keywords

therapeutic plasma exchangeTPElongevity clinicblood purificationapheresisbiohackingfunctional medicinehealthspanturnkey clinical platformbiological age reductionapheresis nursingclinical service deliveryplasma exchange therapyanti-aging medicine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Circulate Health Comparables

Compare Circulate Health with similar companies based on industry and business-model similarity.

Circulate Health comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Global Apheresis, Inc.
81%
Asahi Kasei
61%
Vibrant Practice
58%

Circulate Health Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
StrategicDec 3, 2025
SeedJul 2, 2025

Key People

Founding team and executive leadership

Uri Greenwald

Ex-Founding CEO, Current Board Member

Founding Team

Circulate Health Investors

Notable investors and investment history

Circulate Health investors
InvestorRounds
Khosla VenturesSeed
CSC UpShot VenturesSeed
Seaside VenturesSeed
Scrum VenturesStrategic, Seed
Seaside VenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 3, 2025

    Scrum Ventures participated in the strategic round.

  • Jul 2, 2025

    $12M raised in Seed round.

Circulate Health Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Circulate Health Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Circulate Health's valuation, stock price, and market status.

Firmographic Details

HeadquartersSeattle, Washington
Employee Range23
Year Founded2025
Last FundingDec 3, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?